APCF - Bader,F.; Davis,G.; Dinowitz,M.; Garfinkle,B.; Harvey,J.; Kozak,R.; Lubiniecki,A.; Rubino,M.; Schubert,D.; Wiebe,M.; Woollett,G. - Assessment of risk of bovine spongiform encephalopathy in pharmaceutical products part - 2 - example risk assessment for a hypothetical product - Biopharm - The Technology & Business of Biopharmaceuticals 1998; 11(N3): 18
APCG - Bader,F.; Davis,G.; Dinowitz,M.; Garfinkle,B.; Harvey,J.; Kozak,R.; Lubiniecki,A.; Rubino,M.; Schubert,D.; Wiebe,M.; Woollett,G. - Assessment of risk of bovine spongiform encephalopathy in pharmaceutical products, part 1 - Biopharm - The Technology & Business of Biopharmaceuticals 1998; 11(N1): 20
AGTT - Kozak,R.W.; Gölker,C.F.; Stadler,P. - Transmissible spongiform encephalopathies (TSE): minimizing the risk of transmission by biological/biopharmaceutical products: an industry perspective. - Developments in Biological Standardization 1996; 88: 257-64